Advanced Search

 

Study ID Status Title Patient Level Data
116296 Completed place of Flixovate® in the treatment pathway and its conditions of use in infants aged from 3 to 12 months between 2010 and 2012 by French GPs and private paediatricians
116297 Completed Profile of patients with type 2 diabetes newly treated
116312 Active not recruiting Assessing the rotavirus positive test results in 11 hospitals in Belgium from 2005 to 2013: the RotaBIS study (Rotavirus Belgian Impact Study)
116313 Completed The cost of illness associated with influenza in the United Kingdom
116316 Completed Validation of the new COPD assessment test (CAT) translated into Thai in patients with Chronic Obstructive Pulmonary Disease (COPD)
116317 Completed Sentinel surveillance for influenza requiring hospital admission in Canadian adults
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116320 Completed Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5) (1)
116329 Completed Optimizing the quality of samples used for the evaluation of cell-mediated immune (CMI) responses in antiretroviral therapy (ART)-naïve Human deficiency virus type 1 (HIV-1)-infected subjects
116343 Completed A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
116344 Completed PGx471: Combined pharmacogenetic analysis of IL28B genotypes in TPL108390 and TPL103922
116352 Completed Molecular Characterization of Methicillin-Resistant Staphylococcus aureus isolates from the GSK132322 Phase II a Study
116357 Completed Burden of respiratory syncytial virus (RSV) in the United Kingdom, 1995 to 2009
116358 Completed An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccines GSK2654911A and GSK2654909A administered to adults 18 to 64 years of age
116364 Completed Study FFR116364, a double-blind, placebo-controlled study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116365 Completed Study FFR116365, an open-label study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116371 Completed A Phase 1, Open-Label, Crossover Study to Demonstrate the Bioequivalence of RYTHMOL SR® (propafenone hydrochloride) Manufactured at Two Different Sites Study Listed on ClinicalStudyDataRequest.com
116378 Completed A Single Blind (Sponsor-unblinded), Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of GSK1070806 in the Treatment of Obese Subjects with T2DM. Study Listed on ClinicalStudyDataRequest.com
116387 Completed Epidemiological multinational (Russia, Ukraine and Kazakhstan), retrospective observational study to evaluate medical, economic and social factors in patients with systemic lupus erythematosus in heading rheumatologic centers
116392 Completed A randomised, double blind, placebo-controlled study to investigate the safety, pharmacodynamics and efficacy against allergic reactivity of repeat intranasal administration of the TLR7 agonist GSK2245035 in subjects with respiratory allergies Study Listed on ClinicalStudyDataRequest.com
116402 Completed A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma Study Listed on ClinicalStudyDataRequest.com
116404 Completed Sleepiness and mood in Parkinson's disease and combination treatment with ropinirole and levodopa
116406 Completed A study to test the possibility of cross reaction of the antibodies induced by the ELAPRASE (R) to GSK2788723ELAPRASE is a trade mark owned by a third party
116409 Completed An open-label, randomised, cross-over, single centre study in healthy volunteers to optimise the Rotacap formulation andROTAHALER device for delivery of Fluticasone propionate/salmeterol.
116415 Completed A randomized, double-blind, single dose, four way cross-over study to assess the systemic exposure, systemic pharmacodynamics and safety and tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol following single inhaled doses of Umeclidinium/Vilanterol blend + Fluticasone Furoate, Umeclidinium + Vilanterol, Fluticasone Furoate + Vilanterol and Fluticasone Furoate + Umeclidinium in healthy subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.